Johnson & Johnson said on Friday it will discontinue a mid-stage field study of its experimental pill for prevention of ...

Sanofi has entered into discussions with U.S. private equity firm Clayton Dubilier & Rice to sell a controlling 50% stake in ...

DelveInsight's Pediatric Drugs Market Insights report provides the current and forecast market analysis, individual leading ...

Now that the first round of price negotiations is complete, CMS' new guidelines will provide more time for drugmakers to make ...

Looking forward, the market is expected to reach US$ 16.1 billion by 2032, exhibiting a growth rate (CAGR) of 8.2% during ...

Optinose (OPTN) said that it appointed Terry Kohler as Chief Financial Officer. Most recently, Kohler was the Chief Financial ...

Threatened with sanctions and loss of its agreement with Medicare and Medicaid, J&J is rolling back a plan to give hospitals after-the-fact rebates for 340B drugs.

The growing occurrence of pediatric conditions like HIV, cancer, diabetes, and others is boosting the need for treatments specifically designed for children, making pediatric drug development ...

Doxorubicin Market Doxorubicin Market Dublin, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The "Doxorubicin Market Size, Share & Trends ...

Liposomal Doxorubicin Market Liposomal Doxorubicin Market Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Liposomal ...

The drugmaker could decide to pursue a spinoff of the business if the bids aren't attractive, Bloomberg said, citing people ...

Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the "Over The Counter ...